Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/EDE.0b013e31817307f2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Optimal timing to discontinue respiratory isolation among patients with pulmonary TB.
Clin Infect Dis
December 2024
Pulmonary Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda, MD, USA.
Temporal trends of health disparity in the utilization of curative-intent treatments for hepatocellular carcinoma: are we making progress?
J Gastrointest Surg
September 2024
Division of Surgical Oncology, Carle Illinois College of Medicine, University of Illinois Urbana Champaign, Illinois, United States. Electronic address:
Background: Liver-directed treatments - ablative therapy (AT), surgical resection (SR), liver transplantation (LT), and transarterial chemoembolization (TACE) - improve the overall survival of patients with early-stage hepatocellular carcinoma (HCC). Although racial and socioeconomic disparities affect access to liver-directed therapies, the temporal trends for the curative-intent treatment of HCC remain to be elucidated.
Methods: This study performed chi-square, logistic regression, and temporal trends analyses on data from the Nationwide Inpatient Sample from 2011 to 2019.
Prevalence of Current Restless Legs Syndrome Symptoms Among Patients Treated with Buprenorphine/Naloxone for Opioid Use Disorder.
Nat Sci Sleep
October 2023
Sleep Disorders Clinical Research Program, Massachusetts General Hospital, Boston, MA, USA.
Objective: The purpose of this study was to determine the prevalence of Restless Legs Syndrome (RLS) in patients with Opioid Use Disorder (OUD) taking buprenorphine/naloxone maintenance therapy, and to assess symptom frequency, severity, and sleep disruption due to RLS.
Methods: Surveys inquired about demographic information, amount of time on maintenance treatment, previous drug use, current prescribed medications and alcohol use, and RLS symptoms. Participants were determined to have definite, probable, possible, or no RLS symptoms based on pre-established criteria from the Cambridge-Hopkins Questionnaire.
A Comprehensive Landscape of Malignancy After Double Lung Transplantation.
Transpl Int
September 2023
Department of Internal Medicine, Northwestern Memorial Hospital, Chicago, IL, United States.
Although the association between post-transplant malignancy (PTM) and immunosuppressive therapy after organ transplantation has been studied, an integrated review of PTM after lung transplantation is lacking. We investigated the incidence and types of PTM and its impact on survival following double lung transplantation (DLT). The incidence and type of PTM as well as the annual and cumulative risks of each malignancy after DLT were analyzed.
View Article and Find Full Text PDFAerosol Sampling Outperforms Sputum to Predict Mycobacterium tuberculosis Transmission.
Clin Infect Dis
October 2023
Division of Infectious Diseases, Department of Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CaliforniaUSA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!